Current treatment of community-acquired pneumonia
Authors:
- Adamantia LiapikouAdamantia Liapikou
- Antonio TorresATAntonio Torres
- 10 May 2013
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Pharmacotherapy
- Vol. 14 (10) , 1319-1332
Abstract
Community-acquired pneumonia (CAP) is a leading cause of morbidity and mortality worldwide. Management decisions regarding site of care, extent of assessment and level of treatment are based primarily on disease severity (outpatient, inpatient and ICU admission). Despite the developments in antibiotic therapy, CAP is still the most common infectious cause of death. There are several challenges with the management of CAP, from the accurate diagnosis, decisions about place of therapy and the choice of appropriate antibiotics. An extensive literature review of manuscripts, in PubMed, published in the past 10 years has been performed, using combinations of words and terms appropriate to the concepts of CAP, treatment, guidelines and corticoids. Some empirical antimicrobial regimens, such as macrolides, are still being debated; some new antibiotics and adjunctive therapies (corticoids) have recently been tested. This is a review of current recommended antimicrobials regimens, novel approaches and adjunctive drugs for the treatment of CAP. Effective management of CAP requires risk stratification of patients by severity and proper place of therapy. Additional therapeutic interventions along with antibiotics may help to improve outcome in patients with CAP, especially in severe CAP.Keywords
This publication has 83 references indexed in Scilit:
- The Role of Statins in Prevention and Treatment of Community Acquired Pneumonia: A Systematic Review and Meta-AnalysisPLOS ONE, 2013
- Corticosteroids in the Treatment of Community-Acquired Pneumonia in Adults: A Meta-AnalysisPLOS ONE, 2012
- Cethromycin versus Clarithromycin for Community-Acquired Pneumonia: Comparative Efficacy and Safety Outcomes from Two Double-Blinded, Randomized, Parallel-Group, Multicenter, Multinational Noninferiority StudiesAntimicrobial Agents and Chemotherapy, 2012
- Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of β-lactamsCritical Care, 2011
- Understanding the potential role of statins in pneumonia and sepsis*Critical Care Medicine, 2011
- Effect of corticosteroids on the clinical course of community-acquired pneumonia: a randomized controlled trialCritical Care, 2011
- Efficacy and safety of tigecycline versus levofloxacin for community-acquired pneumoniaBMC Pulmonary Medicine, 2009
- Pharmacodynamic optimization of β-lactams in the patient care settingCritical Care, 2008
- National and Regional Assessment of Antimicrobial Resistance among Community-Acquired Respiratory Tract Pathogens Identified in a 2005-2006 U.S. Faropenem Surveillance StudyAntimicrobial Agents and Chemotherapy, 2007
- Health Care-Associated Pneumonia and Community-Acquired Pneumonia: a Single-Center ExperienceAntimicrobial Agents and Chemotherapy, 2007